Founded by Byekwaso Alex Hilary and Ankunda Sarah Nakabugo, SCRC is to set up a Specialized Cutting Edge Research Laboratory by June 2023 that is to explore the basic biology of hematopoietic stem cells and effector T cells such as natural killer cells, regulatory T cells, cytotoxic T cells and B cells with the aim of getting new medications for blood disorders and a Specialized Sickle Cell Research Hospital by June 2030.

SCRC intends to run a Cell Processing Laboratory where all clinical material is to be prepared for transplantation research and where complex cell separation and expansion protocols can be accomplished. We pride ourselves in the SCRC vision and work plan that is to train physician scientists and performing translational research to find better approaches for the treatment of blood disorder patients and advancement of the blood disorder field.